Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALinC 17 in Standard Risk Acute Lymphoblastic Leukemia
NCT00005596Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2000
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Started Apr 2000; status: completed.
02
Drugs
methotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00005596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005596.